Scinovex
review Open AccessTop 1% cited

Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults

Alimentary Pharmacology & Therapeutics · 2011 · Vol. 34(3) · pp. 274–285
Gregory C. VernonAncha BaranovaZobair M. Younossi

Abstract

Non-alcoholic fatty liver disease is the most common cause of elevated liver enzymes. Within the NAFLD spectrum, only NASH progresses to cirrhosis and hepatocellular carcinoma. With the growing epidemic of obesity, the prevalence and impact of NAFLD continues to increase, making NASH potentially the most common cause of advanced liver disease in coming decades.

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLiver Diseases and ImmunitySteatohepatitisFatty liverMedicineInternal medicineCirrhosisLiver biopsyEpidemiologyAlcoholic liver diseaseMetabolic syndromeHepatocellular carcinoma

MeSH terms

AdultBiopsyFatty LiverHumansPrognosisRisk FactorsPrevalenceNon-alcoholic Fatty Liver Disease
Citations
3,085
FWCI
92.61
field-weighted impact
References
121
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.